Article

5 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 57, n° 4
pages 629-637 (octobre 2007)
Doi : 10.1016/j.jaad.2007.05.029
accepted : 28 May 2007
Reports

Characterization of benign and malignant melanocytic skin lesions using optical coherence tomography in vivo
 

Thilo Gambichler, MD , Philipp Regeniter, BS, Falk G. Bechara, MD, Alexej Orlikov, MD, Remus Vasa, MD, Georg Moussa, MD, Markus Stücker, MD, Peter Altmeyer, MD, Klaus Hoffmann, MD
Department of Dermatology, Ruhr-University Bochum, Bochum, Germany 

Reprint requests: Thilo Gambichler, MD, Department of Dermatology, Ruhr-University Bochum, Gudrunstrasse 56, 44791 Bochum, Germany.
Abstract
Background

Although optical coherence tomography (OCT) is a promising noninvasive imaging technique for the micromorphology of the skin, OCT has not been studied systematically in skin cancer such as malignant melanoma (MM).

Objective

We sought to visualize and characterize melanocytic skin lesions (MSL) by using OCT in vivo, compare OCT features of benign nevi (BN) and MM, and histologically validate the OCT findings.

Methods

In all, 75 patients with 92 MSL, including 52 BN and 40 MM, were included in this study. MSL were investigated by OCT in vivo and consecutive histology. We compared the OCT images with the corresponding histologic slices of BN and MM. To ascertain accuracy of correlation between OCT images and histologic sections, the excised lesions were tattooed according to the level of OCT scanning. For every MSL, serial histologic slices were prepared.

Results

MM often showed a marked architectural disarray (P = .036) and rarely displayed a clear dermoepidermal border (P = .0031) when compared with BN. OCT of MM infrequently demonstrated a dermoepidermal junction zone with finger-shaped elongated rete ridges as typically seen in BN (P = .011). Compared with BN, the papillary and superficial reticular dermis in MM frequently displayed a more diffuse or patchy reflectivity with loss of the typical bright horizontal linear structures (P = .022). However, more or less large vertical, icicle-shaped structures were the most striking OCT feature of MM, which were not observed in BN (P < .001).

Limitations

The diagnostic performance of OCT in the diagnosis of MSL could not be fully determined. Sensitivity and specificity studies also including other skin tumors have not been performed.

Conclusion

In this study, distinct OCT features of MSL could be correlated to histopathologic findings. With regard to the micromorphologic features visualized by OCT, we detected significant differences between BN and MM. These OCT features might serve as useful discriminating parameters of MSL.

The full text of this article is available in PDF format.

Abbreviations used : BN, CLSM, MM, MSL, OCT



 Thilo Gambichler, MD, and Philipp Regeniter, BS, contributed equally to this report.
 Performed in cooperation with the Ruhr Centre of Competence for Medical Engineering (KMR, Bochum, Germany) and supported by the Federal Ministry of Education and Research (BMBF), grant No. 13N8079.



© 2007  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline